GREEN CROSS WellBeing Corporation Logo

GREEN CROSS WellBeing Corporation

Develops personalized nutrition solutions, from prescription injections to supplements & cosmetics.

234690 | KO

Overview

Corporate Details

ISIN(s):
KR7234690006
LEI:
Country:
South Korea
Address:
서울특별시 영등포구 여의대로 108 파크원타워2 33층, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

GREEN CROSS WellBeing Corporation is a healthcare company specializing in personalized nutrition solutions. The company develops, manufactures, and markets a diverse portfolio of products, including prescription nutritional therapy injections, where it is a market leader with products like Laennec. Its offerings also include a wide range of health supplements and functional foods, featuring customized solutions like the Dr.PNT and Dr.Pack brands tailored to individual needs. Other key areas include the development of specialized probiotics for different life stages and a cosmetics line derived from proprietary cell culture technology. The company actively engages in R&D to discover novel functional materials from natural sources and to develop new pharmaceutical treatments.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 1.7 MB
2025-08-01 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.2 KB
2025-06-09 00:00
Governance Information
공정거래자율준수프로그램운영현황
Korean 5.4 KB
2025-05-29 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 1.5 MB
2025-04-30 00:00
Earnings Release
연결재무제표기준영업(잠정)실적(공정공시)
Korean 16.4 KB
2025-04-09 00:00
M&A Activity
[기재정정]타법인주식및출자증권취득결정
Korean 30.8 KB
2025-04-04 00:00
M&A Activity
[기재정정]타법인주식및출자증권취득결정
Korean 31.0 KB
2025-03-25 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 25.0 KB
2025-03-25 00:00
Governance Information
공정거래자율준수프로그램운영현황
Korean 15.6 KB
2025-03-17 00:00
Audit Report / Information
감사보고서제출
Korean 25.0 KB
2025-03-17 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.9 MB
2025-03-10 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 189.6 KB
2025-03-10 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 168.6 KB
2025-02-20 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 93.4 KB

Automate Your Workflow. Get a real-time feed of all GREEN CROSS WellBeing Corporation filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for GREEN CROSS WellBeing Corporation

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for GREEN CROSS WellBeing Corporation via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

CEL SCI CORP Logo
Develops immunotherapies for cancer, autoimmune, and infectious diseases.
United States of America
CVM
Celularity Inc Logo
Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.
United States of America
CELU
Centessa Pharmaceuticals plc Logo
Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.
United States of America
CNTA
CERO THERAPEUTICS HOLDINGS, INC. Logo
Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.
United States of America
CERO
CervoMed Inc. Logo
Developing CNS therapeutics for neurodegenerative diseases like dementia with Lewy bodies.
United States of America
CRVO
Cessatech A/S Logo
Develops a non-invasive nasal spray for acute pain relief in children during medical procedures.
Denmark
CESSA
CG Invites Co., Ltd. Logo
Biopharma advancing precision medicine with drugs, mRNA vaccines, and digital therapeutics.
South Korea
083790
CG Oncology, Inc. Logo
Developing bladder-sparing oncolytic immunotherapies for patients with bladder cancer.
United States of America
CGON
CHA Vaccine Research Institute Logo
Develops vaccines and immunotherapies for infectious diseases and cancer using proprietary platforms.
South Korea
261780
Manufactures veterinary medicines and feed additives for livestock, aquatic animals, and pets.
South Korea
052670

Talk to a Data Expert

Have a question? We'll get back to you promptly.